Review |
From the Department of Physiology (X.Y.), Chinese University of Hong Kong, China; and the Department of Pharmacy & Pharmacology (C.J.G.), University of Bath, United Kingdom.
Correspondence to Xiaoqiang Yao, PhD, Dept of Physiology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China. E-mail yao2068{at}cuhk.edu.hk
This Review is part of a thematic series on Transient Receptor Potential Channels in the Cardiovascular System, which includes the following articles:
Recent Developments in Vascular Endothelial Cell Transient Receptor Potential Channels
Transient Receptor Potential Channels and Possible Functions in Cardiovascular Muscle
Bernd Nilius Guest Editor
| Abstract |
|---|
|
|
|---|
Key Words: transient receptor potential channels Ca2+ influx endothelial cells vascular tone vascular permeability
| Introduction |
|---|
|
|
|---|
Endothelial Ca2+ influx was originally estimated by measuring 45Ca2+ uptake and, more recently, with the patch-clamp technique and by measuring changes in the fluorescence of Ca2+-indicator dyes. Rapid developments in molecular biology have led to the cloning of a large number of Ca2+-permeable channels, many of which are expressed within endothelial cells. These include members of the TRP superfamily, the cyclic nucleotide-gated channel, and the P2X purinoceptor subfamilies.1,2 However, it still remains difficult to directly correlate a cloned channel, especially a cloned TRP channel, with endogenous channel activity recorded from endothelial cells. This is attributable, in part, to a lack of specific compounds with which to block or activate the different channel isoforms, as well as the inherent complexity of these ion channels and the small currents passing through them. Ion channels consist of several subunits, which can be resident as homo- or heteromultimers; unfortunately, the precise subunit composition and the relative stoichiometry of TRP channels are still unclear. This is an important consideration, as heteromultimeric channels may display electrophysiological properties that are quite different from those of the homomultimeric channels.3,4 This, of course, presents a rather circuitous problem, as it is often difficult to determine the molecular identity of native channels recorded in endothelial cells without specific inhibitors and/or activators being available.
In spite of these problems, the evidence available suggests that TRP channels are among the most important Ca2+-permeable channels in vascular endothelial cells. Progress in recent years has resulted in the isolation of 28 unique mammalian TRP isoforms, which have been divided into 6 subfamilies: canonical TRPC, vanilloid TRPV, melastatin TRPM, polycystin TRPP, mucolipin TRPML, and ankyrin transmembrane proteins (TRPA).3,5 TRP channels display a high degree of diversity in cation selectivity, modes of activation, voltage sensitivity, and physiological function.3,4,6 Several recent reviews have extensively discussed the properties and activation mechanisms of different TRP isoforms.35,7 Two excellent review articles by Nilius and colleagues1,8 highlight the important roles played by TRP channels with regard to endothelial cell function. However, the TRP-channel field is rapidly evolving, and at least 10 additional TRP channels have been found in vascular endothelial cells since the last review.8 This is more than double the number of TRP channels originally described in endothelial cells. Furthermore, additional functions have been suggested for many of the original group of TRP channels reported in endothelial cells. Therefore, the purpose of this review is to update the most recent developments by summarizing the current knowledge on expression and function of endothelial cell TRP channels. Cellular/subcellular localization of TRP channels and phosphorylation-linked regulation are also discussed to highlight some general mechanisms for the control of channel activity and function.
| Expression of TRP Channels in Endothelial Cells |
|---|
|
|
|---|
|
|
|
Only a very limited number of studies have investigated TRP expression in the endothelial cells of intact vessels.22,23 Kohler et al23 used the single-cell RT-PCR technique to study the expression of TRPC1 and TRPC3 to 6 in the endothelial cells of intact human mesenteric artery, whereas our group used in situ hybridization and immunohistochemistry to examine TRPC expression within the endothelial cells of intact human coronary and cerebral arteries.22 In addition, several other groups have also used immunohistochemical methods to study the expression of TRPP1 and TRPP2 in the endothelial cells of intact arteries (Table 2).32,33,35 Immunohistochemical studies may also have associated technical problems, because commercially available anti-TRP antibodies frequently are not very specific.37,38
Note that there is still a considerable lack of information on the relative expression levels of the different TRP isoforms within endothelial cells from specific sources. Elucidating the relative expression level of specific TRP isoforms will be essential to enable understanding of the function each one mediates because, quite simply, different TRP isoforms may underpin different vascular functions and because heteromeric coassembly between different TRP isoforms may affect the properties and functions of the channels.
| Functional Role of Endothelial Cell TRP Channels |
|---|
|
|
|---|
Studies with TRPC4 gene knockout mice have indicated a direct functional link between endothelial TRPC4 channels and vascular tone control.13 Recent progress suggests that TRPV1 and TRPV4 also play an important role in the control of vascular tone. TRPV1 and TRPV4 are activated by the endogenous cannabinoids (endocannabinoids) anandamide and 2-arachidonoyl-glycerol (2-AG),42,43 both of which have vascular effects in their own right.42 Endocannabinoids mediate endothelium-dependent and -independent vascular relaxation.43 In some vascular beds, such as the mesentery, endocannabinoid-mediated vascular dilation cannot be fully explained by activation of the classical cannabinoid receptors CB1 or CB2,43 suggesting the possible involvement of TRPV1 and/or TRPV4. In rat mesenteric arteries, anandamide-induced vasorelaxation is predominantly endothelium dependent, and the relaxation is markedly reduced by a TRPV1-specific inhibitor, capsazepine, suggesting a critical role for TRPV1 channels in endothelial cells.44 In human cerebral artery endothelial cells, 2-AG activates TRPV1, and the consequent increase in Ca2+ influx enhances the phosphorylation of vasodilator-stimulated phosphoprotein (VASP), which is a substrate of protein kinase G (PKG) and protein kinase A (PKA). A possible interpretation is that 2-AG activates TRPV1, and the increase in [Ca2+]i stimulates the activity of PKA and/or PKG, thus causing phosphorylation of VASP. PKA and PKG are enzymes known to play an important role in vascular dilation. This suggests that TRPV1-mediated Ca2+ influx may contribute to the regulation of vascular tone through stimulation of PKG and/or PKA.
A substantial amount of recent evidence, mostly from Nilius and colleagues, suggests that TRPV4 has a major role in the control of vascular tone.8,43,45 TRPV4 is highly expressed in endothelial cells,8,30 and the activation of TRPV4 stimulates Ca2+ influx in mouse aortic endothelial cells.43,46 Interestingly, the effect of anandamide on TRPV4 has been found to be attributable to its downstream metabolic product 5',6'-epoxyeicosatrienoic acid (EET).45 Because it has been established that 5',6'-EET is an endogenous vasodilator in some vascular beds,39 the activation of TRPV4 by 5',6'-EET may be the route to vascular relaxation.
Control of Vascular Permeability
Inflammatory mediators such as thrombin and histamine induce vascular leakage, which reflects increased permeability of the vascular endothelium to plasma proteins and other solutes. These inflammatory mediators induce an increase in endothelial cell [Ca2+]i.47 The rise in [Ca2+]i activates key signaling pathways, resulting in myosin light chaindependent endothelial cell contraction and disassembly of vascular endothelial cadherin at the adherens junctions. These events lead to increased vascular permeability.47 Studies with TRPC4 gene knockout mice have demonstrated an important role for this TRPC protein in the control of vascular permeability.20,47 Recent studies indicate that TRPC1, TRPC6, and TRPV1 may also participate in the control of vascular permeability.
A possible role for TRPC1 in the regulation of vascular permeability derives from the studies in which TRPC1 overexpression is found to augment thrombin- and vascular endothelial growth factor (VEGF)-induced increases in transendothelial permeability in confluent human endothelial cell monolayers.18,28 Conversely, inhibition of TRPC1 activity, either by using an anti-TRPC1 antibody or by interfering with the interaction of TRPC1 with inositol trisphosphate receptors (IP3Rs), reduces the VEGF-induced increase in transendothelial permeability.28 Other studies have identified a number of factors that can increase either the expression level or the activity of TRPC1.16,25,26 Tumor necroses factor-
induces TRPC1 expression through a nuclear factor
Bdependent pathway,25 whereas RhoA, activated by thrombin, can associate with both IP3R and TRPC1, which leads to the translocation of a Rho, IP3R, and TRPC1 complex to the plasma membrane.16 Protein kinase C (PKC) directly phosphorylates TRPC1, resulting in increased TRPC1 channel activity.26 Interestingly, although each of these factors (tumor necrosis factor-
, RhoA, and PKC) appears to increase TRPC1 expression or activity by different mechanisms, they each consistently augment thrombin-induced increases in endothelial monolayer permeability, an action reversed by inhibiting these factors.16,18,26 These data, together with an early study that suggested a causal linkage between endothelial cell TRPC1 and cytoskeleton arrangement,17 indicate an important functional role for TRPC1 in the regulation of vascular permeability.
TRPC6 also appears to be involved in the control of endothelial cell permeability. Pocock et al48 found that VEGF evokes a marked elevation in endothelial cell [Ca2+]i in frog mesenteric microvessels associated with a parallel increase in vascular permeability. This [Ca2+]i rise may be a consequence of enhanced Ca2+ influx through TRPC6, because the effect of VEGF can be mimicked by 1-oleoyl-2-acetylglycerol and flufenamic acid, two agents that are known to activate TRPC6.48 These data are consistent with a role for TRPC6 in VEGF-induced increases in vascular permeability; however, similar to most of the available data attempting to link TRP-channel activity to a specific vascular function, the conclusion are clearly not definitive.
As discussed above, activation of TRPV1x2-AG enhances VASP phosphorylation of human cerebral microvessel endothelial cells.31 Because VASP is known to regulate endothelial permeability,49 this study also infers a role for TRPV1 in the control of vascular permeability.
Angiogenesis and Vascular Remodeling
Angiogenic factors, such as VEGF, basic fibroblast growth factor, and platelet-derived growth factor (PDGF), stimulate the proliferation and migration of endothelial cells, thus promoting angiogenesis. Endothelial cytosolic Ca2+ plays an important role in the angiogenic process. Potential roles of TRP-mediated Ca2+ influx in angiogenesis has been extensively reviewed by Nilius and colleagues,1,8 and the possible involvement of TRPC6 in VEGF-induced endothelial cell Ca2+ influx is discussed above. However, another recent development is worth mentioning, which is the recent identification of TRPM6 and TRPM7 in human lung artery endothelial cells.15 Both channels are highly permeable to Mg2+,3,7 and they are crucial for Mg2+ homeostasis. Although there is little information concerning the function of endothelial TRPM6 and -7, the potential importance of these channels should not be underestimated, because Mg2+ is known to have diverse effects on endothelial cell function, including angiogenesis. A direct correlation has been reported between the Mg2+ content of endothelial cells and growth factormediated endothelial cell proliferation.50,51 Mitogenic stimuli increase Mg2+ influx, but Mg2+ deprivation promotes growth arrest by upregulating p27Kip1,51, which is an inhibitor of cyclin-dependent kinase. These data suggest that growth factors may stimulate Mg2+ entry into endothelial cells through TRPM7 channels. The elevated cytosolic Mg2+ then downregulates p27Kip1, relieving inhibition of cyclin-dependent kinase, which results in cell-cycle progression.50,51
The endothelium is also believed to play a major role in the initiation of vascular remodeling. During vascular remodeling, expression of pro-proliferative factors such as VEGF and PDGF-B on the endothelial cells is upregulated. This change contributes to the subsequent alterations in the growth, migration, and differentiation of the smooth muscle cells responsible for arterial remodeling. TRP channels may contribute to vascular remodeling through 2 different mechanisms: (1) proliferative factors may activate TRP channels with the consequent elevation in [Ca2+]i, modulating the signal transduction pathways leading to remodeling; and (2) Ca2+ influx through TRP channel may stimulate endothelial cells to produce and release proliferative factors such as VEGF and PDGF, which then subsequently facilitate vascular remodeling. Recently, Fantozzi et al15 have provided evidence that TRPC4 may participate in hypoxia-induced vascular remodeling. In human pulmonary artery endothelial cells, hypoxia upregulated TRPC4 expression at both the mRNA and protein levels, which correlated directly with and was dependent on capacitative Ca2+ entry and, furthermore, was associated with an increased binding of activator protein-1 to nuclear protein. Because an increased activator protein-1binding activity is expected to promote the transcription of genes encoding vascular growth factors such as VEGF and PDGF, a causal linkage among TRPC4 activation, Ca2+influx, and vascular remodeling can be suggested.
Oxidative Stress
Oxidative stress describes the injury caused to cells resulting from increased formation of reactive oxygen species (ROS) and/or decreased antioxidant reserve. ROS may react with endothelial macromolecules such as DNA, proteins, and lipids, causing extensive damage to cellular structures and eventually cell death. Morphological and functional alteration of the endothelium is preceded by ROS-induced alteration in Ca2+ homeostasis.52 ROS are known to cause a sustained increase in endothelial [Ca2+]i, which activates proteases, alters the cytoskeleton, and eventually leads to endothelial cell dysfunction.52
At least 4 TRP channels, TRPC3,12,53 TRPC4,53 TRPM2,54 and TRPM7,55 are known to be activated by oxidative stress, and all 4 channels are expressed in endothelial cells (Tables 1 and 3
). Therefore, these ROS-sensitive endothelial cell TRP channels may potentially act as sensors for oxidative stress, an interaction that may have very significant physiological and pathological consequences. Furthermore, an ability to downregulate these channels may be a means to protect endothelial cells from oxidative stressinduced cell injury. It was shown that "knocking out" TRPM2 and TRPM7 protein expression, using antisense oligonucleotides and small-interfering RNA, significantly suppresses ROS-induced cell death in rat insulinoma RIN-5F cells and cortical neurons, respectively.54,55 Unpublished data (2005) from our laboratory using RT-PCR and immunoblots in a mouse microvessel endothelial line H5V showed expression of TRPM2. Transfection of the H5V cells with an antisense construct against TRPM2 reduced the expression of TRPM2 protein and also decreased H2O2-induced Ca2+ influx into these cells, suggesting a role for TRPM2 in oxidative stressinduced Ca2+ influx in endothelial cells. In another study, Balzer et al12 showed that the oxidant tert-butylhydroperoxide activates a TRP-like cation conductance in porcine aortic endothelial cells. Expression of an N-terminal fragment of human TRPC3, NTRP3, but not of a C-terminal fragment, CTRP3, abolished the oxidant-induced cation current, suggesting that TRPC3 protein can represent the molecular basis of endothelial oxidant-activated cation channels.12 A follow-up study suggested that oxidative stressinduced disruption of caveolin 1rich lipid raft domains may contribute to the redox modulation of TRPC3.53 To date, however, there has been no direct experimental evidence that can link any of the TRP channels to endothelial cell apoptosis and vascular damage. Future efforts are clearly needed to resolve these issues.
Mechanosensing
Blood flow exerts a viscous drag, or shear stress, on the surface of the endothelial cells that are aligned in the direction of flow. Furthermore, pulsatile stretch on the vascular wall stretches the cell membrane of the endothelial cells. In response to all of these forces, endothelial cells undergo diverse biochemical and physiological responses, which include the release of vasodilator agents, alterations in gene expression, and the secretion of growth factors.56 Many of these responses are dependent on mechanosensitive Ca2+ influx into the endothelial cells. It is not clear whether shear stress and membrane stretch activate the same or different channels. However, in 1 case, a shear stressactivated channel, TRPV4, was shown to be insensitive to membrane stretch.57 The sensitivity of most stretch-activated Ca2+-permeable channels to flow shear stress has not been tested or reported.58,59 On the other hand, some evidence suggests the existence of Ca2+-permeable channels that can be responsive to both membrane stretch and flow shear stress.60 Our group60 has recorded a stretch-activated Ca2+-permeable cation channel in rat aortic endothelial cells with properties similar to the channels reported by others.61,62 There is a striking pharmacological similarity, including the sensitivity to inhibition by PKG, Gd3+, SK&F96365, and Ni2+, between this stretch-activated cation channel and the global increase in endothelial cell [Ca2+]i stimulated by flow.60 These data suggest that the stretch-activated channel may be the primary pathway underlying flow-induced Ca2+ influx in endothelial cells. Subsequent studies have shown that the flow-induced Ca2+ entry into these cells is sensitized by the depletion of intracellular Ca2+ stores,63 suggesting a possible involvement of TRP channels. Brakemeier et al64 have also reported a relationship between flow-induced shear stress and the mechanosensitivity of a stretch-activated Ca2+-permeable channel. In this case, a prolonged shear stress (4 hours) upregulated the density of the channel and increased the sensitivity of the channel to membrane stretch.
Stretch-activated channels expressed in vascular endothelial cells include TRPC158 and TRPV259 (Tables 1 and 2
), and flow-activated channels in these cells include TRPV465 and the complex of TRPP1 (PKD1) and TRPP2 (PKD2) (Table 2).66 However, it is not clear whether these channels are related to the mechanosensitive, Ca2+-permeable channels recorded in endothelial cells and described above.6062 Endothelial cell TRPC1 and TRPV2 may be activated during the pulsatile stretch of the wall of blood vessels, but it is not clear whether they may also respond to shear stress. Molecular candidates for shear stressactivated channels in endothelial cells include TRPV4 and the complex of TRPP1 and TRPP2.65,66 TRPP1 does not form a channel alone but complexes with TRPP2 to form a Ca2+-permeable channel.66 TRPP1 may serve as a sensory molecule that transduces the stimulus provided by fluid flow to TRPP2, which then enables Ca2+ influx.66 TRPP2 has a very large pore diameter (at least 11 Å), which may, therefore, also allow osmolyte permeation.67 Mutations in either the TRPP1 or TRPP2 gene are known to result in a common genetic disease named as autosomal dominant polycystic kidney disease.4,5,68 There is evidence that malfunctions in endothelial cell TRPP1 and TRPP2 may impair the complex regulation of NO synthase, resulting in endothelial cell dysfunction, which may contribute to the progression of autosomal dominant polycystic kidney disease.35,68
TRPA1 is also a potential candidate for endothelial mechanosensitive channels. TRPA1 is expressed in hair-cell stereocilia,69 where the large number of ankyrin domains in the amino terminus of the channel may serve as the gating spring for mechanotransduction. Disruption of TRPA1 in zebrafish and in the mouse impairs hair-cell transduction.69 The TRPML3 channel displays a similar intracellular localization profile to TRPA1 within hair cells, and mutations in TRPML3 result in loss of hearing.70 It is, therefore, tempting to speculate that TRPML3 might complex with TRPA1 to sense mechanical cues in inner-ear hair cells.70,71 Unfortunately, there is no evidence for the expression of TRPA1 and TRPML3 in endothelial cells.
Another possibility is that flow-induced shear stress, membrane stretch, and cell swelling may lead to the generation of endogenous ligands, which might then indirectly activate TRP channels. This has been clearly demonstrated in the case of TRPV4 activation by cell swelling. Cell swelling stimulates phospholipase A2, which produces arachidonic acid,72,73 which is metabolized to 5',6'-EET, leading to the activation of TRPV4.45,74 Interestingly, cell swelling activates TRPV4 by a mechanism distinct from the activation of volume-regulated anion channel (VRAC) by cell swelling. Whereas VRAC is activated by a reduced ionic strength during cell swelling, TRPV4 is not sensitive to the same drop in ionic strength.75 TRPC6 and TRPM4 are other TRP channels that can be indirectly activated via mechanosensitive production of endogenous ligands.7679 In vascular smooth muscle cells of rat resistance arteries, intravascular pressure stimulates the production of diacylglycerol (DAG) and, as a consequence, increases the activity of PKC. PKC activates TRPM4,80,81 whereas DAG directly activates both TRPC67678 and TRPM4.80,81 The activation of TRPC6 and TRPM4 results in membrane depolarization, which leads to an increase in muscle contraction (myogenic tone).76,79 Although this pressure-induced activation of TRPC6 and TRPM4 has been reported in only vascular smooth muscle cells, it is likely that a similar mechanism may operate in vascular endothelial cells, because these cells also contain TRPC6 and TRPM4 (Tables 1 and 3
) and components that are required to generate DAG, such as phospholipase C (PLC).82
Endothelial cells, therefore, express multiple TRP channels that may serve as mechanosensors, including stretch-activated (TRPC1 and TRPV2), shear stressactivated (TRPV4 and TRPP1/2), and pressure-activated (TRPM4 and TRPC6) channels. However, no experimental evidence exists to directly link any of these channels to the global increase in endothelial cell [Ca2+]i that can be evoked by pressure or shear-stress challenge. Therefore, again, there are very important issues that are still to be resolved.
Membrane Potential Regulation
Membrane potential is one of the driving forces for Ca2+ entry into endothelial cells. It has been documented that membrane hyperpolarization enhances endothelial Ca2+ influx, whereas the depolarization has the opposite effect,1,41,83 although there is also evidence that the changes in membrane potential per se may not necessarily have significant roles in agonist-evoked [Ca2+]i increase in native endothelial cells in situ.84 However, as most TRP channels are Ca2+ permeable nonselective channels, may actually help to regulate endothelial cell membrane potential. Two different mechanisms may contribute. (1) Ca2+ entry through TRP channels may stimulate Ca2+-sensitive K+ channels in endothelial cells, resulting in a membrane hyperpolarization. (2) Channel opening will allow inflow of positive ions such as Na+ and Ca2+. Therefore, in the absence of a strong counter effect attributable to activation of Ca2+-sensitive K+ channels, the TRP channels may cause membrane depolarization, an effect that has been demonstrated with TRPC6 in smooth muscle cells.76
TRPM4 and -5 are unique in that they carry monovalent cations Na+ and K+ but are essentially impermeable to Ca2+. Opening these channels results in membrane depolarization, decreasing the potential driving force for Ca2+ entry. The expression of TRPM4,6,15 but not TRPM5,15 has been detected in endothelial cells, and as discussed previously, TRPM4-mediated membrane depolarization may be an important component of mechanosensing.79 In addition, because the activity of TRPM4 channels is sensitive to cytosolic ATP and NO,8,85 TRPM4-mediated membrane depolarization may also be important in sensing the metabolic state of the endothelial cells and/or cytosolic NO level.8
Temperature Sensitivity
TRPV1 to 4, TRPM8, and TRPA1 are all temperature-sensitive Ca2+-permeable channels.7,86 TRPV1, -2, and -4 and TRPM8 are expressed in endothelial cells (Tables 2 and 3
).15,30,31,86 TRPV1 and TRPV2 are activated at
43°C and
53°C, respectively, although these threshold values can be modulated under certain conditions.86 Because of their high-temperature thresholds, TRPV1 and TRPV2 might allow increased endothelial Ca2+ influx and NO release at high temperature, thus contributing to peripheral vascular dilation at high temperature.86 TRPV4 activation becomes apparent at temperatures >25 to 27°C63,86; therefore, the channels may be constitutively open at body temperature and contribute to the basal endothelial cell [Ca2+]i level and the steady-state release of NO from the endothelium.8 Decreased TRPV4 activity at colder temperatures may then serve to reduce endothelial Ca2+ influx, contributing to the vasoconstriction that occurs at temperatures down to &12°C. TRPM8 opens at &28°C, and its activity increases as temperature decreases, reaching a plateau at &10°C.7,86 The channel is also able to respond to cooling agents such as menthol and icilin.7,86 TRPM8 mRNA is expressed in human pulmonary artery endothelial cells,15 and, in addition, functional analyses have suggested a putative TRPM8-mediated Ca2+-influx pathway in cultured human corneal endothelial cells.87 However, it is unclear whether and how this channel within endothelial cells could be associated with peripheral vasoconstriction at low temperature.
| General Considerations for Endothelial TRP-Channel Function |
|---|
|
|
|---|
As mentioned previously, PKC activates TRPC1 by directly phosphorylating on TRPC1 protein. The resulting increase in Ca2+ entry is essential for thrombin-induced increases in endothelial monolayer permeability.26 Endothelial cells also express a variety of other TRP channels, the activity of which is known to be regulated by protein phosphorylation at least in other cell types. These include TRPC3 to 7, TRPV1, TRPV4, TRPM4, and TRPM7 (Tables 1 to 3![]()
). In general, protein phosphorylation appears to increase the activity of TRP channels. For example, PKC phosphorylation increases the activity of TRPM4,80,81 whereas a nonreceptor tyrosine kinase Fyn directly phosphorylates and, as a consequence, activates TRPC6 channels expressed in COS-7 cells.89 Src phosphorylation enhances the activity of TRPM7 in brain microglia,90 and it also participates in the muscarinic receptor or DAG-mediated activation of TRPC3 in HEK293 cells.91 Multiple protein kinases, including PKC, calmodulin-dependent protein kinase II, and PKA, can activate or sensitize TRPV1.92 Finally, one report suggests that Lyn kinase may activate TRPV4 through phosphorylation on Tyr253,93 but this result has been disputed.74
Evidence suggests that protein phosphorylation may also downregulate the activity of some TRP channels. PKC can inhibit the activity of 2 TRPC subfamilies, TRPC3, -6, and -7 and TRPC4 and -5.9496 The PKC-mediated inhibition of TRPC3 reflects the direct PKC phosphorylation of Ser712.97 PKG is another kinase that is capable of inhibiting TRPC3 activity.98 PKG has been shown to phosphorylate Thr11 and Ser263 of TRPC3 proteins and, as a result, inactivate TRPC3.98 Protein-sequence alignment shows that 2 PKG phosphorylation sites on TRPC3 proteins, RRxT11 and RRKLS263MQC, are conserved in both TRPC6 and TRPC7, thus suggesting that PKG may also inhibit TRPC6 and TRPC7. An inhibitory influence of PKC and PKG on TRPC may represent an important negative-feedback mechanism controlling cytosolic Ca2+ levels in endothelial cells (Figure 1). In these negative-feedback pathways, the activation of TRPC results in Ca2+ entry; the rise in cytosolic Ca2+, together with elevated DAG levels, stimulates PKC activity, which feeds back to inactivate the TRPC channels.95 The elevation of cytosolic [Ca2+]i will also stimulate endothelial cell NO synthase activity, leading to increased production of cGMP. This secondary messenger will activate PKG, the ensuing phosphorylation inhibiting TRPC channel activity and completing a PKG-dependent negative-feedback loop.98100 Both the PKC- and PKG-mediated negative feedback may play important roles in the regulation of Ca2+ influx in endothelial cells and may serve to protect the endothelial cells from the detrimental effects of excessive NO, Ca2+, and PKC activation.95,98102
|
TRP Channels and Caveolae
Caveolae are 50- to 100-nm diameter plasmalemma vesicles that are abundant in endothelial cells. They comprise 95% of the cell surface vesicles and equate to &15% of endothelial cell volume.103 Caveolae function as signaling platforms, within which an array of signaling molecules can interact with each other. A number of different TRP isoforms have been identified in association with caveolae and may participate in caveolae-modulated Ca2+ signaling. TRPC3 is assembled in a caveolar Ca2+-signaling complex with a number of other proteins such as IP3R, sarco/endoplasmic reticulum calcium ATPase, G
q/11, IPLC-ß, and caveolin-1 in TRPC3-overexpressing HEK cells.104 Other studies have identified TRPC1 and TRPC4 within the caveolae of rat spleen sinus endothelial cells and mouse interstitial cells of Cajal, respectively.8,24 Recently, TRPC1 and TRPV6 has been reported to interact with VRAC in the caveolae of human prostate cell LNCaP.105 TRPC1 and TRPV6 allow Ca2+ influx by a capacitative Ca2+-entry mechanism that inhibits VRAC. Disruption of the caveolar microdomain with methyl-ß-cyclodextrin uncouples the association between VRAC and TRP channels and impairs the regulation of VRAC by Ca2+. Therefore, these data suggest that TRP channels may regulate VRAC within the caveolae and, in so doing, participate in the regulation of cell volume.
Convergence and Divergence of TRP-Mediated Signaling Pathways
We have presented a large body of evidence showing that endothelial cells express many different TRP isoforms and suggesting that these channels may play quite diverse physiological/pathophysiological roles within the circulatory system. Why then do endothelial cells possess so many different TRP channels, when each can cause a very similar increase in cytosolic [Ca2+]i level? There are at least 2 likely explanations.
First, the variety of TRP channels with different mechanisms of activation and modulation will provide the cells with a selection of channels that enable Ca2+ inflow under different conditions. For example, TRPC4 is activated when endothelial cells are exposed to an agonist such as ATP,13 whereas TRPV1 is activated when the cells are in contact with endocannabinoids,31,42,44 and TRPV4 is activated when the cells are stimulated by endocannabinoids and mechanical stress.43 Subsequent elevation of [Ca2+]i within discrete cell compartments as a consequence of the activation of these individual TRP channels may then be linked to the synthesis and release of vasorelaxant compounds such as NO, prostacyclin, and EDHF within endothelial cells. In this example, the signaling pathways triggered by the stimulation of different TRP channels converge to exert a common response, the release of a vasodilator.
Second, the activity of different TRP isoforms may result in different functional responses. This could be attributable to the differences in channel properties, such as the ion permeability profile and Ca2+ sensitivity of a specific TRP isoform or to differential expression of TRP channels in endothelial cells derived from different vascular beds or, more subtly, to differential expression within different subcellular compartments of endothelial cells. Endothelial cells from different vascular beds may contain enzymes and proteins responsible for a specific function(s) in that region. Similarly, different subcellular compartments or different regions of the cytoplasm in a particular group of endothelial cells may contain specific enzymes and proteins.106 It is easy to see how this could have important functional implications. For example, TRPC5 is expressed in the endothelial cells of human coronary arteries but not in those of human pulmonary arteries that express TRPC4 (Table 1). Therefore, TRPC5 may underlie endothelial functions in human coronary arteries, and TRPC4 underlies those in human pulmonary arteries. In another example, TRPC1 is expressed in the caveolae of rat spleen sinus endothelial cells.24 Caveolae may only express a limited number of TRP isoforms.107 Therefore, activation of TRPC1 may be associated with caveolae-related functional changes, such as modulation of endothelial NO synthase and VRAC, but the activation of TRP channels that are not present in the caveolae will have different functional consequences.
Another unresolved issue is why the activation of a single TRP isoform can sometimes lead to different functional changes. For example, activation of TRPV1 causes endothelium-dependent vascular dilation, and it also increases vascular permeability.31,44 Another example is that activation of TRPC4 causes endothelium-dependent vasorelaxation, and it also increases vascular permeability and enhances hypoxia-induced vascular remodeling.13,20 One explanation for this functional diversity may be the concurrent expression of a single TRP isoform in endothelial cells from different vascular beds and/or in several different subcellular compartments within a given endothelial cell type. TRPC1 was found to be localized in the plasma membrane, caveolae, and lateral plasma membranes of adjoining endothelial cells of sinus endothelial cells in rat spleen.24 It is reasonable to speculate that TRPC1 in the lateral plasma membrane of the adjoining endothelial cells may participate in the disassembly of vascular endothelial cadherin at the adherens junctions and that the TRPC1 in caveolae may regulate endothelial NO synthase and VRAC. In this way, the signaling pathway downstream of a particular TRP isoform diverges to initiate multiple functional responses.
| Summary and Goals for the Future |
|---|
|
|
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Yamamoto K, Korenaga R, Kamiya A, Ando J. Fluid shear stress activates Ca2+ influx into human endothelial cells via P2X4 purinoceptors. Circ Res. 2000; 87: 385391.
3. Montell C. The TRP superfamily of cation channels. Sci STKE. 2005; 272: RE3.
4. Minke B, Cook B. TRP channel proteins and signal transduction. Physiol Rev. 2002; 82: 429472.
5. Moran MM, Xu H, Clapham DE. TRP ion channels in the nervous system. Curr Opin Neurobiol. 2004; 14: 362369.[CrossRef][Medline] [Order article via Infotrieve]
6. Nilius B, Prenen J, Droogmans G, Voets T, Vennekens R, Freichel M, Wissenbach U, Flockerzi V. Voltage dependence of the Ca2+-activated cation channel TRPM4. J Biol Chem. 2003; 278: 3081330820.
7. Fleig A, Penner R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol Sci. 2004; 25: 633639.[CrossRef][Medline] [Order article via Infotrieve]
8. Nilius B, Droogmans G, Wondergem R. Transient receptor potential channels in endothelium: solving the calcium entry puzzle? Endothelium. 2003; 10: 515.[CrossRef][Medline] [Order article via Infotrieve]
9. Antoniotti S, Lovisolo D, Fiorio Pla A, Munaron L. Expression and functional role of bTRPC1 channels in native endothelial cells. FEBS Lett. 2002; 510: 189195.[CrossRef][Medline] [Order article via Infotrieve]
10. Chang AS, Chang SM, Garcia RL, Schilling WP. Concomitant and hormonally regulated expression of trp genes in bovine aortic endothelial cells. FEBS Lett. 1997; 415: 335340.[CrossRef][Medline] [Order article via Infotrieve]
11. Garcia RL, Schilling WP. Differential expression of mammalian TRP homologues across tissues and cell lines. Biochem Biophys Res Commun. 1997; 239: 279283.[CrossRef][Medline] [Order article via Infotrieve]
12. Balzer M, Lintschinger B, Groschner K. Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells. Cardiovas Res. 1999; 42: 543549.
13. Freichel M, Suh SH, Pfeifer A, Schweig U, Trost C, Weissgerber P, Biel M, Philipp S, Freise D, Droogmans G, Hofmann F, Flockerzi V, Nilius B. Lack of an endothelial store-operated Ca2+ current impairs agonist-dependent vasorelaxation in TRP4/ mice. Nat Cell Biol. 2001; 3: 121127.[CrossRef][Medline] [Order article via Infotrieve]
14. Brough GH, Wu S, Cioffi D, Moore TM, Li M, Dean N, Stevens T. Contribution of endogenously expressed Trp1 to a Ca2+-selective, store-operated Ca2+ entry pathway. FASEB J. 2001; 15: 17271738.
15. Fantozzi I, Zhang S, Platoshyn O, Remillard CV, Cowling RT, Yuan JX. Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2003; 285: L1233L1245.
16. Mehta D, Ahmmed GU, Paria BC, Holinstat M, Voyno-Yasenetskaya T, Tiruppathi C, Minshall RD, Malik AB. RhoA interaction with inositol 1,4,5-trisphosphate receptor and transient receptor potential channel-1 regulates Ca2+ entry. Role in signaling increased endothelial permeability. J Biol Chem. 2003; 278: 3349233500.
17. Moore TM, Brough GH, Babal P, Kelly JJ, Li M, Stevens T. Store-operated calcium entry promotes shape change in pulmonary endothelial cells expressing Trp1. Am J Physiol. 1998; 275: L574L582.[Medline] [Order article via Infotrieve]
18. Paria BC, Vogel SM, Ahmmed GU, Alamgir S, Shroff J, Malik AB, Tiruppathi C. Tumor necrosis factor-alpha-induced TRPC1 expression amplifies store-operated Ca2+ influx and endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L1303L1313.
19. Kamouchi M, Philipp S, Flockerzi V, Wissenbach U, Mamin A, Raeymaekers L, Eggermont J, Droogmans G, Nilius B. Properties of heterologously expressed hTRP3 channels in bovine pulmonary artery endothelial cells. J Physiol. 1999; 518: 345358.
20. Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, Malik AB. Impairment of store-operated Ca2+ entry in TRPC4/ mice interferes with increase in lung microvascular permeability. Circ Res. 2002; 91: 7076.
21. McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, Yuan JX. Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L870L880.
22. Yip H, Chan WY, Leung PC, Kwan HY, Liu C, Huang Y, Michel V, Yew DT, Yao X. Expression of TRPC homologs in endothelial cells and smooth muscle layers of human arteries. Histochem Cell Biol. 2004; 122: 553561.[CrossRef][Medline] [Order article via Infotrieve]
23. Kohler R, Brakemeier S, Kuhn M, Degenhardt C, Buhr H, Pries A, Hoyer J. Expression of ryanodine receptor type 3 and TRP channels in endothelial cells: comparison of in situ and cultured human endothelial cells. Cardiovasc Res. 2001; 52: 160168.
24. Uehara K. Localization of TRPC1 channel in the sinus endothelial cells of rat spleen. Histochem Cell Biol. 2005; 123: 347357.[CrossRef][Medline] [Order article via Infotrieve]
25. Paria BC, Malik AB, Kwiatek AM, Rahman A, May MJ, Ghosh S, Tiruppathi C. Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cells. J Biol Chem. 2003; 278: 3719537203.
26. Ahmmed GU, Mehta D, Vogel S, Holinstat M, Paria BC, Tiruppathi C, Malik AB. Protein kinase Calpha phosphorylates the TRPC1 channel and regulates store-operated Ca2+ entry in endothelial cells. J Biol Chem. 2004; 279: 2094120949.
27. Groschner K, Hingel S, Lintschinger B, Balzer M, Romanin C, Zhu X, Schreibmayer W. Trp proteins form store-operated cation channels in human vascular endothelial cells. FEBS Lett. 1998; 437: 101106.[CrossRef][Medline] [Order article via Infotrieve]
28. Jho D, Mehta D, Ahmmed G, Gao XP, Tiruppathi C, Broman M, Malik AB. Angiopoietin-1 opposes VEGF-induced increase in endothelial permeability by inhibiting TRPC1-dependent Ca2+ influx. Circ Res. 2005; 96: 12821290.
29. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A. 2001; 98: 1217412179.
30. Wissenbach U, Bodding M, Freichel M, Flockerzi V. Trp12, a novel Trp related protein from kidney. FEBS Lett. 2000; 485: 127134.[CrossRef][Medline] [Order article via Infotrieve]
31. Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res Mol Brain Res. 2004; 132: 8792.[Medline] [Order article via Infotrieve]
32. Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. Am J Pathol. 1999; 154: 17211729.
33. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, Van Raay T, Bradley J, Qian F, Onuchic LF, Watnick TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger KW. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A. 1997; 94: 63976402.
34. Markowitz GS, Cai Y, Li L, Wu G, Ward LC, Somlo S, DAgati VD. Polycystin-2 expression is developmentally regulated. Am J Physiol. 1999; 277: F17F25.[Medline] [Order article via Infotrieve]
35. Kim K, Drummond I, Ibraghimov-Beskrovnaya O, Klinger K, Arnaout MA. Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A. 2000; 97: 17311736.
36. Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, Ibraghimov-Beskrovnaya O, Klinger K, Sandford R. Cellular and Subcellular Distribution of Polycystin-2, the Protein Product of the PKD2 Gene. J Am Soc Nephrol. 2000; 11: 814827.
37. Flockerzi V, Jung C, Aberle T, Meissner M, Freichel M, Philipp SE, Nastainczyk W, Maurer P, Zimmermann R. Specific detection and semi-quantitative analysis of TRPC4 protein expression by antibodies. Pflugers Arch. In press.
38. Ong HL, Chen J, Chataway T, Brereton H, Downs T, Tsiokas L, Barritt G. Specific detection of the endogenous transient receptor potential (TRP)-1 protein in liver and airway smooth muscle cells using immunoprecipitation and Western-blot analysis. Biochem J. 2002; 364: 641648.[CrossRef][Medline] [Order article via Infotrieve]
39. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH. EDHF: bringing the concepts together. Trends Pharmacol Sci. 2002; 23: 374380.[CrossRef][Medline] [Order article via Infotrieve]
40. Mather S, Dora KA, Sandow SL, Winter P, Garland CJ. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circ Res. 2005; 97: 399407.
41. Luckhoff A, Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflugers Arch. 1990; 416: 305311.[CrossRef][Medline] [Order article via Infotrieve]
42. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003; 140: 790801.[CrossRef][Medline] [Order article via Infotrieve]
43. Nilius B, Vriens J, Prenen J Droogmans G, Voets T. TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol Cell Physiol. 2004; 286: C195C205.
44. Domenicali M, Ros J, Fernandez-Varo G, Cejudo-Martin P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodes J, Jimenez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors. Gut. 2005; 54: 522527.
45. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003; 424: 434438.[CrossRef][Medline] [Order article via Infotrieve]
46. Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem. 2002; 277: 4704447051.
47. Tiruppathi C, Minshall RD, Paria BC, Vogel SM, Malik AB. Role of Ca2+ signaling in the regulation of endothelial permeability. Vasc Pharmacol. 2002; 39: 173185.[CrossRef]
48. Pocock TM, Foster RR, Bates DO. Evidence of a role for TRPC channels in VEGF-mediated increased vascular permeability in vivo. Am J Physiol Heart Circ Physiol. 2004; 286: H1015H1026.
49. Comerford KM, Lawrence DW, Synnestvedt K, Levi BP, Colgan SP. Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability. FASEB J. 2002; 16: 583585.
50. Wolf FI, Cittadini A. Magnesium in cell proliferation and differentiation. Front Biosci. 1999; 4: d607d617.[CrossRef][Medline] [Order article via Infotrieve]
51. Sgambato A, Wolf FI, Faraglia B, Cittadini A. Magnesium depletion causes growth inhibition, reduced expression of cyclin D1, and increased expression of P27Kip1 in normal but not in transformed mammary epithelial cells. J Cell Physiol. 1999; 180: 245254.[CrossRef][Medline] [Order article via Infotrieve]
52. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hyperten. 2000; 18: 655673.[CrossRef][Medline] [Order article via Infotrieve]
53. Groschner K, Rosker C, Lukas M. Role of TRP channels in oxidative stress. Novartis Found Symp. 2004; 258: 222230.[Medline] [Order article via Infotrieve]
54. Hara Y, Wakamori M, Ishii M, Maeno E, Nishida M, Yoshida T, Yamada H, Shimizu S, Mori E, Kudoh J, Shimizu N, Kurose H, Okada Y, Imoto K, Mori Y. LTRPC2 Ca2+-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol Cell. 2002; 9: 163173.[CrossRef][Medline] [Order article via Infotrieve]
55. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, MacDonald JF, Tymianski M. A key role for TRPM7 channels in anoxic neuronal death. Cell. 2003; 115: 863877.[CrossRef][Medline] [Order article via Infotrieve]
56. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995; 75: 519560.
57. Strotmann R, Harteneck C, Nunnenmacher K, Schultz G, Plant TD. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol. 2000; 2: 695702.[CrossRef][Medline] [Order article via Infotrieve]
58. Maroto R, Raso A, Wood TG, Kurisky A, Martinac B, Hamill OP. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nature Cell Biol. 2005; 7: 179185.[CrossRef][Medline] [Order article via Infotrieve]
59. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Yuji Imaizumi Y. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res. 2003; 93: 829838.
60. Yao X, Kwan HY, Chan FL, Chan NW, Huang Y. A protein kinase G-sensitive channel mediates flow-induced Ca2+ entry into vascular endothelial cells. FASEB J. 2000; 14: 932938.
61. Lansman JB, Hallam TJ, Rink TJ. Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers? Nature. 1987; 325: 811813.[CrossRef][Medline] [Order article via Infotrieve]
62. Marchenko SM, Sage SO. A novel mechanosensitive cationic channel from the endothelium of rat aorta. J Physiol. 1997; 498: 419425.
63. Kwan HY, Leung PC, Huang Y, Yao X. Depletion of intracellular Ca2+ stores sensitizes the flow-induced Ca2+ influx in rat endothelial cells. Circ Res. 2003; 92: 286292.
64. Brakemeier S, Eichler I, Hopp H, Köhler R, Hoyer J. Up-regulation of endothelial stretch-activated cation channels by fluid shear stress. Cardiovasc Res. 2002; 53: 209218.
65. Gao X, Wu L, ONeil RG. Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways. J Biol Chem. 2003; 278: 2712927137.
66. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet. 2003; 33: 129137.[CrossRef][Medline] [Order article via Infotrieve]
67. Anyatonwu GI, Ehrlich BE. Organic cation permeation through the channel formed by polycystin-2. J Biol Chem. 2005; 280: 2948829493.
68. Devuyst O, Persu A, Vo-cong MT. Autosomal dominant polycystic kidney disease: modifier genes and endothelial dysfunction. Nephrol Dial Transplant. 2003; 18: 22112215.
69. Corey DP, García-Añoveros J, Holt JR, Kwan KY, Lin SY, Vollrath MA, Amalfitano A, Cheung ELM, Derfler BH, Duggan A, Géléoc GS, Gray PA, Hoffman MP, Rehm HL, Tamasauskas D, Zhang DS. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature. 2004; 432: 723730.[CrossRef][Medline] [Order article via Infotrieve]
70. Di Palma F, Belyantseva IA, Kim HJ, Vogt TF, Kachar B, Noben-Trauth K. Mutations in Mcoln3 associated with deafness and pigmentation defects in varitint-waddler (Va) mice. Proc Natl Acad Sci U S A. 2002; 99: 1499414999.
71. Qian F, Noben-Trauth K. Cellular and molecular function of mucolipins (TRPML) and polycystin 2 (TRPP2). Pflugers Arch. In press.
72. Oike M, Droogmans G, Nilius B. Mechanosensitive Ca2+ transients in endothelial cells from human umbilical vein. Proc Natl Acad Sci U S A. 1994; 91: 29402944.
73. Thoroed SM, Lauriezen L, Lambert IH, Hansen HS, Hoffmann EK. Cell swelling activates phospholipase A2 in Ehrlich ascites tumor cells. J Membr Biol. 1997; 160: 4758.[CrossRef][Medline] [Order article via Infotrieve]
74. Vriens J, Watanabe H, Janssens A, Droogmans G, Voets T, Nilius B. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4. Proc Natl Acad Sci U S A. 2004; 101: 396401.
75. Nilius B, Prenen J, Wissenbach U, Bodding M, Droogman G. Differential activation of the volume-sensitive cation channel TRP12 (OTRPC4) and volume-regulated anion currents in HEK-293 cells. Pflugers Arch. 2001; 443: 227233.[CrossRef][Medline] [Order article via Infotrieve]
76. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res. 2002; 90: 248250.
77. Slish DF, Welsh DG, Brayden JE. Diacylglycerol and protein kinase C activate cation channels involved in myogenic tone. Am J Physiol Heart Circ Physiol. 2002; 283: H2196H2201.
78. Park KS, Kim Y, Lee YH, Earm YE, Ho WK. Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ Res. 2003; 93: 557564.
79. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res. 2004; 95: 922929.
80. Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A, Voets T, Zhu MX. Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem. 2005; 280: 64236433.
81. Guinamard R, Chatelier A, Lenfant J, Bios P. Activation of the Ca2+-activated nonselective cation channel by diacylglycerol analogues in rat cardiomyocytes. J Cardiovasc Electrophysiol. 2004; 15: 342348.[Medline] [Order article via Infotrieve]
82. Avdinin P, Ryan US, Hayes B. Receptor-dependent regulation of [Ca2+]i and phospholipase C in vascular endothelial cells. J Recept Signal Transduct Res. 2000; 20: 235254.[Medline] [Order article via Infotrieve]
83. Kamouchi M, Trouet D, De Greef C, Droogmans G, Eggermont J, Nilius B. Functional effects of expression of hslo Ca2+ activated K+ channels in cultured macrovascular endothelial cells. Cell Calcium. 1997; 22: 497506.[CrossRef][Medline] [Order article via Infotrieve]
84. McSherry IN, Spitaler MM, Takano H, Dora KA. Endothelial cell Ca2+ increases are independent of membrane potential in pressurized rat mesenteric arteries. Cell Calcium. 2005; 38: 2333.[CrossRef][Medline] [Order article via Infotrieve]
85. Nilius B, Prenen J, Voets T, Droogmans G. Intracellular nucleotides and polyamines inhibit the Ca2+-activated cation channel TRPM4b. Pflugers Arch. 2004; 448: 7075.[CrossRef][Medline] [Order article via Infotrieve]
86. Tominaga M, Caterina MJ. Thermosensation and pain. J Neurobiol. 2004; 61: 312.[CrossRef][Medline] [Order article via Infotrieve]
87. Mergler S, Pleyer U, Reinach P, Bednarz J, Dannowski H, Engelmann K, Hartmann C, Yousif T. EGF suppresses hydrogen peroxide induced Ca2+ influx by inhibiting L-type channel activity in cultured human corneal endothelial cells. Exp Eye Res. 2005; 80: 285293.[CrossRef][Medline] [Order article via Infotrieve]
88. Parekh AB, Putney JW Jr. Store depletion and calcium influx. Physiol Rev. 2005; 85: 757810.
89. Hisatsune C, Kuroda Y, Nakamura K, Inoue T, Nakamura T, Michikawa T, Mizutani A, Mikoshiba K. Regulation of TRPC6 channel activity by tyrosine phosphorylation. J Biol Chem. 2004; 279: 1888718894.
90. Jiang X, Newell EW, Schlichter LC. Regulation of a TRPM7-like current in rat brain microglia. J Biol Chem. 2003; 278: 4286742876.
91. Vazquez G, Wedel BJ, Kawasaki BT, Bird GS, Putney JW Jr. Obligatory role of Src kinase in the signaling mechanism for TRPC3 cation channels. J Biol Chem. 2004; 279: 4052140528.
92. Nagy I, Santha P, Gábor Jancso G, Urban L. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol. 2004; 500: 351369.[CrossRef][Medline] [Order article via Infotrieve]
93. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem. 2003; 278: 1152022527.
94. Trebak M, St J Bird G, McKay RR, Birnbaumer L, Putney JW Jr. Signaling mechanism for receptor-activated canonical transient receptor potential 3 (TRPC3) channels. J Biol Chem. 2003; 278: 1624416252.
95. Venkatachalam K, Zheng F, Gill DL. Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C. J Biol Chem. 2003; 278: 2903129040.
96. Zhang L, Saffen D. Muscarinic acetylcholine receptor regulation of TRP6 Ca2+ channel isoforms. Molecular structures and functional characterization. J Biol Chem. 2001; 276: 1333113339.
97. Trebak M, Hempel N, Wedel BJ, Smyth JT, Bird GSJ, Putney JW Jr. Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712. Mol Pharmacol. 2005; 67: 558563.
98. Kwan HY, Huang Y, Yao X. Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G. Proc Natl Acad Sci U S A. 2004; 101: 26252630.
99. Yao X, Huang Y. From nitric oxide to endothelial cytosolic Ca2+: a negative feedback control. Trends Pharmacol Sci. 2003; 24: 263266.[CrossRef][Medline] [Order article via Infotrieve]
100. Kwan HY, Huang Y, Yao X. Store-operated calcium entry in vascular endothelial cells is inhibited by cGMP via a protein kinase G-dependent mechanism. J Biol Chem. 2000; 275: 67586763.
101. Choy JC, Granville DJ, Hunt DW, McManus BM. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol. 2001; 33: 16731690.[CrossRef][Medline] [Order article via Infotrieve]
102. Rask-Madsen C, King GL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol. 2005; 25: 487496.
103. Predescu D, Palade GE. Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol Heart Circ Physiol. 1993; 265: H725H733.
104. Lockwich T, Singh BB, Liu X, Ambudkar IS. Stabilization of cortical actin induces internalization of transient receptor potential 3 (Trp3)-associated caveolar Ca2+ signaling complex and loss of Ca2+ influx without disruption of Trp3-inositol trisphosphate receptor association. J Biol Chem. 2001; 276: 4240142408.
105. Vanden Abeele F, Shuba Y, Roudbaraki M, Lemonnier L, Vanoverberghe K, Mariot P, Skryma R, Prevarskaya N. Store-operated Ca2+ channels in prostate cancer epithelial cells: function, regulation, and role in carcinogenesis. Cell Calcium. 2003; 33: 357373.[CrossRef][Medline] [Order article via Infotrieve]
106. Barritt GJ. Receptor-activated Ca2+ inflow in animal cells: a variety of pathways tailored to meet different intracellular Ca2+ signalling requirements. Biochem J. 1999; 337: 153169.[CrossRef][Medline] [Order article via Infotrieve]
107. Trevino CL, Serrano CJ, Beltran C, Felix R, Darszon A. Identification of mouse trp homologs and lipid rafts from spermatogenic cells and sperm. FEBS Lett. 2001; 509: 119125.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. A. Mendoza, J. Fang, D. D. Gutterman, D. A. Wilcox, A. H. Bubolz, R. Li, M. Suzuki, and D. X. Zhang TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress Am J Physiol Heart Circ Physiol, February 1, 2010; 298(2): H466 - H476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ditting, G. Tiegs, K. Rodionova, P. W. Reeh, W. Neuhuber, W. Freisinger, and R. Veelken Do distinct populations of dorsal root ganglion neurons account for the sensory peptidergic innervation of the kidney? Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1427 - F1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Thodeti, B. Matthews, A. Ravi, A. Mammoto, K. Ghosh, A. L. Bracha, and D. E. Ingber TRPV4 Channels Mediate Cyclic Strain-Induced Endothelial Cell Reorientation Through Integrin-to-Integrin Signaling Circ. Res., May 8, 2009; 104(9): 1123 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, A. L. Gonzales, and R. Crnich Endothelium-Dependent Cerebral Artery Dilation Mediated by TRPA1 and Ca2+-Activated K+ Channels Circ. Res., April 24, 2009; 104(8): 987 - 994. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang, S. A. Mendoza, A. H. Bubolz, A. Mizuno, Z.-D. Ge, R. Li, D. C. Warltier, M. Suzuki, and D. D. Gutterman Transient Receptor Potential Vanilloid Type 4-Deficient Mice Exhibit Impaired Endothelium-Dependent Relaxation Induced by Acetylcholine In Vitro and In Vivo Hypertension, March 1, 2009; 53(3): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Bode, Y.-Y. Cho, D. Zheng, F. Zhu, M. E. Ericson, W.-Y. Ma, K. Yao, and Z. Dong Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis Cancer Res., February 1, 2009; 69(3): 905 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Smedlund and G. Vazquez Involvement of Native TRPC3 Proteins in ATP-Dependent Expression of VCAM-1 and Monocyte Adherence in Coronary Artery Endothelial Cells Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 2049 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Willette, W. Bao, S. Nerurkar, T.-l. Yue, C. P. Doe, G. Stankus, G. H. Turner, H. Ju, H. Thomas, C. E. Fishman, et al. Systemic Activation of the Transient Receptor Potential Vanilloid Subtype 4 Channel Causes Endothelial Failure and Circulatory Collapse: Part 2 J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaudhuri, S. M. Colles, M. Bhat, D. R. Van Wagoner, L. Birnbaumer, and L. M. Graham Elucidation of a TRPC6-TRPC5 Channel Cascade That Restricts Endothelial Cell Movement Mol. Biol. Cell, August 1, 2008; 19(8): 3203 - 3211. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Bratz, G. M. Dick, J. D. Tune, J. M. Edwards, Z. P. Neeb, U. D. Dincer, and M. Sturek Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2489 - H2496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-T. Cheng, Y.-K. Leung, B. Shen, Y.-C. Kwok, C.-O. Wong, H.-Y. Kwan, Y.-B. Man, X. Ma, Y. Huang, and X. Yao CNGA2 Channels Mediate Adenosine-Induced Ca2+ Influx in Vascular Endothelial Cells Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 913 - 918. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ledoux, A. D. Bonev, and M. T. Nelson Ca2+-activated K+ Channels in Murine Endothelial Cells: Block by Intracellular Calcium and Magnesium J. Gen. Physiol., January 28, 2008; 131(2): 125 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Larsen, D. X. Zhang, and D. D. Gutterman Epoxyeicosatrienoic Acids, TRP Channels, and Intracellular Ca2+ in the Vasculature: An Endothelium-Derived Endothelium-Hyperpolarizing Factor? Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2496 - 2498. [Full Text] [PDF] |
||||
![]() |
D. L. Cioffi The Skinny on TRPV1 Circ. Res., April 13, 2007; 100(7): 934 - 936. [Full Text] [PDF] |
||||
![]() |
I. Singh, N. Knezevic, G. U. Ahmmed, V. Kini, A. B. Malik, and D. Mehta G{alpha}q-TRPC6-mediated Ca2+ Entry Induces RhoA Activation and Resultant Endothelial Cell Shape Change in Response to Thrombin J. Biol. Chem., March 16, 2007; 282(11): 7833 - 7843. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-R. E. Curry and C. A. Glass TRP Channels and the Regulation of Vascular Permeability: New Insights From the Lung Microvasculature Circ. Res., October 27, 2006; 99(9): 915 - 917. [Full Text] [PDF] |
||||
![]() |
D. F. Alvarez, J. A. King, D. Weber, E. Addison, W. Liedtke, and M. I. Townsley Transient Receptor Potential Vanilloid 4-Mediated Disruption of the Alveolar Septal Barrier: A Novel Mechanism of Acute Lung Injury Circ. Res., October 27, 2006; 99(9): 988 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Inoue, L. J. Jensen, J. Shi, H. Morita, M. Nishida, A. Honda, and Y. Ito Transient Receptor Potential Channels in Cardiovascular Function and Disease Circ. Res., July 21, 2006; 99(2): 119 - 131. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |